Free Trial

Addus HomeCare (NASDAQ:ADUS) Stock Price Expected to Rise, Macquarie Analyst Says

Addus HomeCare logo with Medical background

Addus HomeCare (NASDAQ:ADUS - Get Free Report) had its price target lifted by investment analysts at Macquarie from $129.00 to $133.00 in a research note issued on Thursday,Benzinga reports. The brokerage currently has an "outperform" rating on the stock. Macquarie's price target would suggest a potential upside of 19.92% from the stock's current price.

Several other equities research analysts also recently commented on ADUS. StockNews.com downgraded Addus HomeCare from a "buy" rating to a "hold" rating in a report on Wednesday, February 26th. JMP Securities reaffirmed a "market outperform" rating and issued a $150.00 target price on shares of Addus HomeCare in a research report on Tuesday, April 22nd. Oppenheimer raised their price target on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a report on Friday, January 24th. Finally, Stephens reissued an "overweight" rating and issued a $142.00 price objective on shares of Addus HomeCare in a research note on Wednesday, March 12th. One equities research analyst has rated the stock with a hold rating, six have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Buy" and an average target price of $142.57.

View Our Latest Stock Report on Addus HomeCare

Addus HomeCare Trading Up 0.2 %

Addus HomeCare stock traded up $0.21 during mid-day trading on Thursday, reaching $110.91. The company's stock had a trading volume of 146,372 shares, compared to its average volume of 165,038. The business has a 50 day moving average price of $98.86 and a 200-day moving average price of $114.26. Addus HomeCare has a twelve month low of $88.96 and a twelve month high of $136.72. The firm has a market cap of $2.04 billion, a price-to-earnings ratio of 25.38, a PEG ratio of 1.41 and a beta of 0.85.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, beating analysts' consensus estimates of $1.33 by $0.09. The company had revenue of $337.71 million for the quarter, compared to analysts' expectations of $341.66 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business's revenue for the quarter was up 20.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.21 earnings per share. On average, equities analysts expect that Addus HomeCare will post 4.59 EPS for the current fiscal year.

Hedge Funds Weigh In On Addus HomeCare

Several large investors have recently added to or reduced their stakes in the company. Barclays PLC boosted its position in shares of Addus HomeCare by 204.8% during the 3rd quarter. Barclays PLC now owns 43,470 shares of the company's stock valued at $5,783,000 after acquiring an additional 29,207 shares in the last quarter. Franklin Resources Inc. increased its stake in shares of Addus HomeCare by 2.7% in the 3rd quarter. Franklin Resources Inc. now owns 26,216 shares of the company's stock valued at $3,456,000 after buying an additional 701 shares during the period. Principal Financial Group Inc. raised its holdings in Addus HomeCare by 17.5% during the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company's stock worth $67,293,000 after purchasing an additional 75,409 shares during the last quarter. JPMorgan Chase & Co. raised its stake in shares of Addus HomeCare by 10.2% during the third quarter. JPMorgan Chase & Co. now owns 183,198 shares of the company's stock worth $24,371,000 after buying an additional 16,997 shares during the last quarter. Finally, GAMMA Investing LLC lifted its stake in shares of Addus HomeCare by 34.5% in the 4th quarter. GAMMA Investing LLC now owns 1,258 shares of the company's stock valued at $158,000 after purchasing an additional 323 shares during the period. Institutional investors and hedge funds own 95.35% of the company's stock.

About Addus HomeCare

(Get Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Further Reading

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines